Related Experiment Videos
The comparative efficacy and safety of 5% povidone-iodine cream for topical antisepsis
Abstract:
A 5% povidone-iodine cream (Betadine Cream, The Purdue Frederick Company, Norwalk, Conn.) was tested extensively to determine its safety and efficacy. Results of in vitro microbiologic comparison found that a representative panel of vegetative test organisms couldn't be recovered after 60 seconds or less exposure to povidone-iodine (PVP-I) cream, whereas the kill time of the combination-antibiotic cream (Neosporin Cream, Burroughs Wellcome, Research Triangle Park, NC) exceeded 15 minutes for at least half of vegetative organisms. PVP-I cream produced a log reduction of Bacillus pumilis spores after less than one hour's exposure; the antibiotic cream did not. Both PVP-I and antibiotic creams were essentially non-irritating in human and in vivo animal studies. In open wounds, 5% PVP-I cream caused little or no burning and pain upon application. In human comparisons, artificially induced, standardized lesions inoculated with Staphylococcus aureus, were treated twice daily with PVP-I cream or triple-antibiotic ointment (Neosporin Ointment, Burroughs Wellcome, Research Triangle Park, NC) over three weeks. Both caused significantly reduced bacterial counts (p less than 0.001), and significantly faster healing (p less than 0.05) than no treatment.
Insights
Povidone-iodine (PVP-I) cream demonstrates superior antimicrobial efficacy compared to antibiotic creams, rapidly eliminating vegetative organisms and spores. Both formulations were found safe and effective in wound healing studies.
Area of Science:
- Microbiology
- Dermatology
- Infectious Diseases
Background:
- Topical antimicrobial agents are crucial for wound management.
- Povidone-iodine (PVP-I) and antibiotic creams are commonly used.
- Comparative efficacy and safety data are essential for clinical guidance.
Purpose of the Study:
- To evaluate the in vitro and in vivo safety and efficacy of a 5% povidone-iodine (PVP-I) cream.
- To compare the antimicrobial activity of PVP-I cream against a combination-antibiotic cream.
- To assess the healing potential of PVP-I cream in experimentally induced skin lesions.
Main Methods:
- In vitro microbiologic testing against vegetative organisms and Bacillus pumilis spores.
- In vivo animal and human studies to assess irritation potential.
- Clinical comparison of PVP-I cream versus triple-antibiotic ointment on Staphylococcus aureus-inoculated lesions.
Main Results:
- PVP-I cream exhibited rapid kill times (<60 seconds) against vegetative organisms, significantly faster than antibiotic cream (>15 minutes).
- PVP-I cream achieved log reduction of Bacillus pumilis spores, while the antibiotic cream did not.
- Both PVP-I and antibiotic creams were non-irritating. PVP-I cream showed minimal burning/pain in open wounds.
- In human trials, both PVP-I cream and antibiotic ointment significantly reduced bacterial counts and accelerated healing compared to no treatment.
Conclusions:
- 5% Povidone-iodine cream possesses potent and rapid antimicrobial properties against a broad spectrum of microorganisms, including spores.
- PVP-I cream demonstrates favorable safety and tolerability profiles, comparable to antibiotic formulations.
- PVP-I cream is an effective option for promoting wound healing by reducing bacterial burden.